Meridia Officially Off Market After Sibutramine Linked to Heart Attacks

The list prescription that covers all manner of weight loss drugs looks set to dwindle again for patients seeking pharmaceutical help to banish obesity. Abbott Laboratories announced that it is voluntarily pulling off its promising drug Meridia from the U.S. pharmaceutical market amidst concerns of elevated heart disease side effects. The list prescription drug had been FDA approved for use in 1997.

Mon, 10/11/2010 - 05:30